HilleVax, Inc. (HLVX)
NASDAQ: HLVX · Real-Time Price · USD
1.970
+0.020 (1.03%)
Jun 27, 2025, 4:00 PM - Market closed
HilleVax Market Cap
HilleVax has a market cap or net worth of $97.72 million as of June 27, 2025. Its market cap has decreased by -83.40% in one year.
Market Cap
97.72M
Enterprise Value
-37.78M
1-Year Change
-83.40%
Ranking
Category
Stock Price
$1.97
Market Cap Chart
Since the IPO on April 29, 2022, HilleVax's market cap has decreased from $538.26M to $97.72M, a decrease of -81.84%. That is a compound annual growth rate of -41.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 93.26M | -6.60% |
| Dec 31, 2024 | 99.85M | -86.63% |
| Dec 29, 2023 | 746.58M | 25.20% |
| Dec 30, 2022 | 596.32M | 10.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |